Osiris Therapeutics, Inc. EPS - Earnings per Share 2010-2018 | OSIR
Osiris Therapeutics, Inc. eps - earnings per share from 2010 to 2018. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Osiris Therapeutics, Inc. Annual EPS |
| 2018 |
$1.07 |
| 2017 |
$0.25 |
| 2016 |
$-0.11 |
| 2015 |
$-1.04 |
| 2014 |
$-0.05 |
| 2013 |
$1.25 |
| 2012 |
$-0.34 |
| 2011 |
$0.45 |
| 2010 |
$0.40 |
| 2009 |
$0.45 |
| Osiris Therapeutics, Inc. Quarterly EPS |
| 2018-12-31 |
$0.95 |
| 2018-09-30 |
$0.12 |
| 2018-06-30 |
$0.07 |
| 2018-03-31 |
$-0.07 |
| 2017-12-31 |
$0.06 |
| 2017-09-30 |
$0.22 |
| 2017-06-30 |
$0.02 |
| 2017-03-31 |
$-0.05 |
| 2015-12-31 |
$-1.09 |
| 2015-09-30 |
$-0.02 |
| 2015-06-30 |
$0.03 |
| 2015-03-31 |
$0.04 |
| 2014-12-31 |
$0.02 |
| 2014-09-30 |
$0.02 |
| 2014-06-30 |
$-0.05 |
| 2014-03-31 |
$-0.04 |
| 2013-12-31 |
$1.50 |
| 2013-09-30 |
$-0.05 |
| 2013-06-30 |
$-0.12 |
| 2013-03-31 |
$-0.08 |
| 2012-12-31 |
$-0.08 |
| 2012-09-30 |
$-0.09 |
| 2012-06-30 |
$-0.13 |
| 2012-03-31 |
$-0.04 |
| 2011-12-31 |
$0.16 |
| 2011-09-30 |
$0.12 |
| 2011-06-30 |
$0.05 |
| 2011-03-31 |
$0.12 |
| 2010-12-31 |
$0.14 |
| 2010-09-30 |
$0.14 |
| 2010-06-30 |
$0.05 |
| 2010-03-31 |
$0.07 |
| 2009-12-31 |
$0.49 |
| 2009-09-30 |
$-0.19 |
| 2009-06-30 |
$-0.30 |
| 2009-03-31 |
$0.45 |
